Showing results (111-120 of 154) with videos related to
Sort By:
Pageof 16
The Journal of Pathology|May 1, 2015
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantationFederica Rascio, Paola Pontrelli, Matteo Accetturo, et al.International Journal of Molecular Sciences|August 27, 2021
CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) ActivationPaola Pontrelli, Margherita Gigante, Federica Spadaccino, et al.Clinical Kidney Journal|December 11, 2025
Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experienceLaura Econimo, Diego Toso, Giovambattista Capasso, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2012
Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responsesClaudio Procaccini, Veronica De Rosa, Mario Galgani, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 17, 2022
mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipientsGiuseppe S Netti, Barbara Infante, Dario Troise, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 18, 2022
Extracellular vesicles derived from patients with antibody-mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal cellsRossana Franzin, Alessandra Stasi, Fabio Sallustio, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 13, 2012
Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled studyGiovanni Stallone, Barbara Infante, Giuseppe Grandaliano, et al.Journal of Nephrology|March 7, 2016
Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluriaAlessandra Pelle, Alessandra Cuccurullo, Cecilia Mancini, et al.Frontiers in Medicine|July 17, 2020
Low C3 Serum Levels Predict Severe Forms of STEC-HUS With Neurologic InvolvementGiuseppe Stefano Netti, Luisa Santangelo, Leonardo Paulucci, et al.Aging|April 30, 2020
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinomaGiuseppe Stefano Netti, Giuseppe Lucarelli, Federica Spadaccino, et al.Pageof 16